Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Adhesion Barrier for Open Heart Surgery

By HospiMedica staff writers
Posted on 10 Sep 2003
A new bioresorbable adhesion barrier is designed to prevent or reduce the formation of adhesions on the surface of the heart after open heart surgery.

Postoperative adhesions are a prevalent and serious complication of open heart surgical procedures. More...
A pivotal clinical trial to assess the efficacy of the new barrier, called Repel-CV, is being planned that will involve around 15 pediatric cardiac surgery centers. The trial will specifically address the effectiveness of Repel-CV to prevent and reduce adhesion formation in neonatal patients who require a staged series of procedures. The results of the trial will be used to obtain approval from the US Food and Drug Administration (FDA), which if received would represent the first such adhesion barrier approved by the agency.

The adhesion barrier was developed by Life Medical Sciences, Inc. (Oceanport, NJ), a biomaterials company engaged in the development and commercialization of innovative and cost-effective medical devices. The company intends to develop a broad range of bioresorbable polymer products to prevent or reduce postoperative adhesions.




Related Links:
Life Medical Sciences

Gold Member
Neonatal Heel Incision Device
Tenderfoot
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Patient Preoperative Skin Preparation
BD ChloraPrep
Radiofrequency Generator
GX1
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.